In March, the FDA for the first time approved a naloxone nasal spray, sold under the Narcan brand, for use without a prescription. Torres to introduce bill requiring disclosure of AI content ...
"On the heels of the FDA's recent approval of the first over-the-counter opioid reversal agent [Narcan], the availability ... Health News // 4 days ago FDA approves second RSV vaccine for people ...
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak ... free sale of Emergent Biosolutions' (EBS.N) Narcan nasal spray, which is a naloxone-based drug ...
A new nasal spray can reverse the effects of an opioid overdose. The Food and Drug Administration gave its stamp of approval to Opvee, which can be used on patients 12 years and older. The product ...
In the latest federal push, the FDA recently approved Narcan to be sold over the counter. The change will allow the new version of the drug to be stocked in grocery stores, vending machines and ...
"On the heels of the FDA's recent approval of the first over-the-counter opioid reversal agent [Narcan], the availability of nalmefene nasal spray places a new prescription opioid reversal option ...
In March, the FDA for the first time approved a naloxone nasal spray, sold under the Narcan brand, for use without a prescription. The FDA press release stated that drugs like fentanyl accounted ...
In March, the FDA, for the first time, approved a naloxone nasal spray, sold under the Narcan brand, for use without a prescription. The FDA press release stated that drugs like fentanyl accounted ...
In March, the FDA, for the first time, approved a naloxone nasal spray, sold under the Narcan brand, for use without a prescription. The FDA press release stated that drugs like fentanyl accounted ...
In March, the FDA, for the first time, approved a naloxone nasal spray, sold under the Narcan brand, for use without a prescription. The FDA press release stated that drugs like fentanyl accounted ...
New HIV infection rates drop thanks to progress in young people, but US still not on track In March, the FDA, for the first time, approved a naloxone nasal spray, sold under the Narcan brand ...
New HIV infection rates drop thanks to progress in young people, but US still not on track In March, the FDA, for the first time, approved a naloxone nasal spray, sold under the Narcan brand ...
